Advancing Risk Analysis of COVID-19 Clinical Predictors: The Case of Fasting Blood Glucose

Frontiers in Medicine

Barrak Alahmad¹  Fahd Al-Mulla²  Abdullah A. Al-Shammari³  Hamad Ali⁴ 

[1] Department of Environmental Health, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, United States;Department of Genetics and Bioinformatics, Dasman Diabetes Institute (DDI), Kuwait City, Kuwait;Department of Genetics and Bioinformatics, Dasman Diabetes Institute (DDI), Kuwait City, Kuwait;Department of Mathematics, Faculty of Sciences, Kuwait University, Kuwait City, Kuwait;Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Health Sciences Center, Kuwait University, Kuwait City, Kuwait;Department of Genetics and Bioinformatics, Dasman Diabetes Institute (DDI), Kuwait City, Kuwait;

关键词: COVID-19;    risk analysis;    nonlinearity;    glucose;    clinical outcomes;    diabetes;    glycolysis;    inflammation;   

DOI  :  10.3389/fmed.2021.636065

来源: Frontiers

【 授权许可】

CC BY